{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:47:03Z","timestamp":1788479223670,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.gtc.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T03:42:49Z","timestamp":1544672569000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Refractory Celiac Disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Georgia","family":"Malamut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2018.09.010_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/gut.52.4.518","article-title":"Fracture experience of patients with coeliac disease: a population based survey","volume":"52","author":"Thomason","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2018.09.010_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cgh.2007.12.022","article-title":"Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet","volume":"6","author":"Cosnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2018.09.010_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gut.30.3.333","article-title":"Malignancy in coeliac disease\u2013effect of a gluten free diet","volume":"30","author":"Holmes","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2018.09.010_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/apt.12621","article-title":"Predictors of persistent villus atrophy in coeliac disease: a population-based study","volume":"39","author":"Lebwohl","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2018.09.010_bib5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1210\/jc.2013-3164","article-title":"Persistent mucosal damage and risk of fracture in celiac disease","volume":"99","author":"Lebwohl","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gtc.2018.09.010_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-159-3-201308060-00006","article-title":"Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study","volume":"159","author":"Lebwohl","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gtc.2018.09.010_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1572-0241.2003.07284.x","article-title":"Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease","volume":"98","author":"Vahedi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: Mayo Clinic Rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2018.09.010_bib9","first-page":"133","article-title":"Tropical sprue: revisited","volume":"54","author":"Khokhar","year":"2004","journal-title":"J\u00a0Pak Med Assoc"},{"key":"10.1016\/j.gtc.2018.09.010_bib10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.010_bib11","doi-asserted-by":"crossref","first-page":"e0125024","DOI":"10.1371\/journal.pone.0125024","article-title":"Gastrointestinal disorder associated with olmesartan mimics autoimmune enteropathy","volume":"10","author":"Scialom","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gtc.2018.09.010_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","article-title":"The incidence and clinical spectrum of refractory celiac disease in a North American referral center","volume":"106","author":"Roshan","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.11.026","article-title":"Celiac disease and its complications: a time traveller's perspective","volume":"136","author":"West","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2018.09.010_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2018.09.010_bib15","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy associated T\u00a0cell lymphoma: retrospective evaluation of single centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2018.09.010_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2018.09.010_bib18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ajg.2011.105","article-title":"Is refractory celiac disease more severe in old Europe?","volume":"106","author":"Malamut","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2018.09.010_bib19","doi-asserted-by":"crossref","first-page":"e0136745","DOI":"10.1371\/journal.pone.0136745","article-title":"Application of deamidated gliadin antibodies in the follow-up of treated celiac disease","volume":"10","author":"de Chaisemartin","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.gtc.2018.09.010_bib20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ajg.2016.439","article-title":"Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients","volume":"111","author":"Comino","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/gutjnl-2015-310148","article-title":"Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing","volume":"66","author":"Moreno","year":"2017","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.gtc.2018.09.010_bib22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/ajg.2012.199","article-title":"Diagnostic yield of capsule endoscopy in refractory celiac disease","volume":"107","author":"Barret","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2018.09.010_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2018.09.010_bib25","doi-asserted-by":"crossref","unstructured":"Cheminant M, Bruneau J, Malamut G, et\u00a0al. NKP46 is a useful diagnostic biomarker in gastrointestinal T-cell lymphoproliferative diseases. A CELAC network study. ICDS (17th International Celiac disease symposium) New Delhi, India, September 2017.","DOI":"10.1002\/hon.2437_26"},{"key":"10.1016\/j.gtc.2018.09.010_bib26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2012.08.028","article-title":"Large Granular Lymphocytic Leukemia complicating Celiac disease: a rare cause of refractory celiac disease","volume":"143","author":"Malamut","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.010_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","article-title":"Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features","volume":"12","author":"Malamut","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2018.09.010_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MCG.0b013e31823eff20","article-title":"TCRbeta clonality improves diagnostic yield of TCRgamma clonality in refractory celiac disease","volume":"46","author":"Perfetti","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.010_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/gutjnl-2016-311816","article-title":"T-cell repertoires in refractory coeliac disease","volume":"67","author":"Ritter","year":"2018","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.gtc.2018.09.010_bib30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jclinpath-2018-205023","article-title":"Clonal T\u00a0cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease","volume":"71","author":"Hussein","year":"2018","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.gtc.2018.09.010_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","article-title":"Azathioprine and prednisone combination therapy in refractory coeliac disease","volume":"18","author":"Goerres","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2018.09.010_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.52.3.347","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T\u00a0cell lymphoma","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2018.09.010_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T\u00a0cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gtc.2018.09.010_bib34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.gtc.2018.09.010_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2018.09.010_bib36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/MEG.0000000000001168","article-title":"A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease","volume":"30","author":"Hrdlickova","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2018.09.010_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","article-title":"Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue","volume":"125","author":"Verkarre","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2018.09.010_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.gtc.2018.09.010_bib39","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0016-5085(03)01047-3","article-title":"Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease","volume":"125","author":"Mention","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2018.09.010_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrmicro2541","article-title":"Genome-virome interactions: examining the role of common viral infections in complex disease","volume":"4","author":"Foxman","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.gtc.2018.09.010_bib41","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.010_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2018.09.010_bib43","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.2005.089987","article-title":"A\u00a0severe but reversible refractory sprue","volume":"55","author":"Dray","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2018.09.010_bib44","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T\u00a0cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2018.09.010_bib45","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gtc.2018.09.010_bib46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.gtc.2018.09.010_bib47","series-title":"AMG 714 (anti-IL-15 Mab) halts the progression of aberrant intraepithelial lymphocytes in refractory celiac disease type II (RCDII): a phase 2A randomized, double blind, placebo-controlled study evaluating AMG714 in adult patients with RCDII\/pre-EATL","author":"Cellier","year":"2018"},{"issue":"4","key":"10.1016\/j.gtc.2018.09.010_bib48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","article-title":"Refractory celiac disease: from bench to bedside","volume":"34","author":"Malamut","year":"2012","journal-title":"Semin Immunopathol"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855318300864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:13:48Z","timestamp":1775304828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855318300864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0889855318300864"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2018.09.010","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory Celiac Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}